Expanded Program On Immunization

Expanded Program on Immunization

Background and Definition

Expanded Program on Immunization (EPI), established in 1987, aimes at guaranteeing the right of every child in Lebanon, regardless of social status or parent's education level, on immunization and protection from diseases that have available effective and safe vaccines. In order to ensure that, the Ministry of Public Health guarantees the provision of vaccines in 700 health care centers, public and social, in collaboration with the private sector and with the conitnuous awareness of care givers about the importance of immunization. The program provides further special attention to chidlren residing in remote and underprivileged areas through quality outreach activities.

EPI ِAims at:

Elevating routine vaccination coverage per district to above 95%.
Preserving Lebanon as polio-free, considering the continuous influx of Syrian refugees and in preparation to the eradication of polio in the region and worldwide.
Eradicating Measles and Rubella by the end of year 2018.

EPI Activities:

Continuous training and capacity building throughout the year for health care workers on routine vaccination management and implementation in all districs.
Continuous work to keep Lebanon certified polio-free
Implementation of the RED STRATEGY to reach every child, which includes:
1. Data on the immunization coverage for children under one year of age
2. Data on immunization coverage in Lebanon
3. Identification of the number of drop-outs and planning to ensure their vaccination per district accordingly
Celebrating World Immunization Week and planning awareness sessions over Lebanon about routine vaccination
Conducting National and Mop-Up Immunization campaigns annually, including vaccination against Measles, Rubella, and Mumps
Conducting regular visits by the self-assessment team to follow on the quality of vaccination delivery service
Continuous collaboration with UNICEFand WHO to follow-up on updates related to immunization worldwide and ensuring implementation in Lebanon considering national and international commitments
Continuous collaboration with the private sector (General Practictioners and Pediatricians) to ensure vaccination for all children in Lebanon, particularly during immunization campaigns and routine immunization.

...

188

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
B02BD02	XYNTHA	BioTech	Moroctocog alfa - 500IU	500IU	Injectable lyophilised powder for solution+diluent	L.L
A11CC05	HI DEE	G	Vitamin D3 - 5000IU	5000IU	Capsule, soft gelatin	740,457 L.L
A11CC05	D-ESTER	G	Vitamin D3 - 50000IU	50000IU	Capsule	1,187,701 L.L
A11CC05	HI DEE	G	Vitamin D3 - 50000IU	50000IU	Capsule, soft gelatin	518,723 L.L
A11CC05	MEGAVIT-D 50	G	Vitamin D3 - 50000IU	50000IU	Capsule	1,940,253 L.L
A11CC05	MEGAVIT-D 50	G	Vitamin D3 - 50000IU	50000IU	Capsule	3,687,248 L.L
A07AA02	MEDISTAN	G	Nystatin - 500,000IU/5ml	500,000IU/5ml	Suspension	415,951 L.L
A07AA02	MEDISTAN	G	Nystatin - 500,000IU	500,000IU	Capsule	417,231 L.L
A11CC05	DIBASE	G	Vitamin D3 - 50000IU/2.5ml	50,000IU/2.5ml	Solution	755,239 L.L
A11CC05	ALTUM	G	Vitamin D3 - 50,000IU	50,000IU	Capsule, hard	712,620 L.L
A11CC05	BIODAL	G	Vitamin D3 - 50,000IU	50,000IU	Tablet, film coated	1,110,014 L.L
A11CC05	D-VITAL	G	Vitamin D3 - 50,000IU	50,000IU	Capsule, hard	712,620 L.L
A11CC05	EURO D HP 50.000 IU	G	Vitamin D3 - 50,000IU	50,000IU	Capsule	1,432,536 L.L
B05CX01	GLUCOSE INJ.	G	Glucose - 10g/20ml	50%	Injectable solution	5,038,066 L.L
M03AX01	XEOMIN	BioTech	Clostridium botulinum type A neurotoxin complex - 50 units LD50	50 units LD50	Injectable powder for solution	11,920,109 L.L
B01AB12	HIBOR	G	Bemiparin Sodium - 5,000IU	5,000IU	Injectable solution	1,466,132 L.L
D06AX	PENICILLIN DERMIC OINTMENT	G	Penicillin - 5,000IU	5,000IU	Ointment	80,631 L.L
G03GA01	CHORIOMON	BioHuman	Human Chorionic Gonadotrophin - 5,000IU	5,000IU	Injectable lyophilised powder for solution+diluent	6,306,653 L.L
B05CX01	5% DEXTROSE INJECTION USP	G	Glucose - 5%	5%	Injectable solution	148,244 L.L
B05CX01	5% DEXTROSE INJECTION USP	G	Glucose - 5%	5%	Injectable solution	148,244 L.L
B05CX01	5% DEXTROSE INJECTION USP	G	Glucose - 5%	5%	Injectable solution	159,736 L.L
B05CX01	5% DEXTROSE INJECTION USP	G	Glucose - 5%	5%	Injectable solution	179,272 L.L
B05CX01	5% DEXTROSE INJECTION USP	G	Glucose - 5%	5%	Injectable solution	191,913 L.L
B05CX01	5% DEXTROSE INJECTION USP	G	Glucose - 5%	5%	Injectable solution	191,913 L.L
B05CX01	5% DEXTROSE INJECTION USP	G	Glucose - 5%	5%	Injectable solution	208,002 L.L
J06BA02	IMMUNOREL	BioHuman	Human normal immunoglobulin - 5g/100ml	5%	Injectable solution	29,700,912 L.L
B05CX01	5% DEXTROSE INJECTION USP	G	Glucose - 5%	5%	Injectable solution	224,090 L.L
J06BA02	IMMUNOREL	BioHuman	Human normal immunoglobulin - 2.5g/50ml	5%	Injectable solution	14,850,456 L.L
B05CX01	5% DEXTROSE INJECTION USP	G	Glucose - 5%	5%	Injectable solution	148,244 L.L
B05CX01	DEXTROSE 5% INJECTION USP	G	Glucose - 5%	5%	Injectable solution	158,587 L.L

...

188